Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27018098)

Published in J Cell Physiol on April 14, 2016

Authors

K van der Meijden1, N Bravenboer2, N F Dirks2, A C Heijboer2, M den Heijer1, G M J de Wit3, C Offringa3, P Lips2, R T Jaspers3

Author Affiliations

1: Department of Internal Medicine/Endocrinology, VU University Medical Center, MOVE Research Institute Amsterdam, Amsterdam, The Netherlands.
2: Department of Clinical Chemistry, VU University Medical Center, MOVE Research Institute Amsterdam, Amsterdam, The Netherlands.
3: Laboratory for Myology, MOVE Research Institute Amsterdam, Department of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Articles citing this

Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells. Endocr Connect (2017) 0.76

Articles cited by this

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60

Vitamin D physiology. Prog Biophys Mol Biol (2006) 4.13

Nonclassic actions of vitamin D. J Clin Endocrinol Metab (2008) 3.71

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol (2003) 3.41

Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab (2007) 2.68

The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology (2014) 2.16

Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem (1985) 2.07

Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil (1999) 1.99

Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69

Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab (2006) 1.58

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone (2007) 1.52

Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int (2010) 1.46

The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism? Eur J Appl Physiol (2010) 1.36

Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem (1981) 1.33

Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J (2006) 1.31

Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Invest (1979) 1.25

The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab (2011) 1.22

Relevance of vitamin D in muscle health. Rev Endocr Metab Disord (2012) 1.19

1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology (2011) 1.18

Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res (2007) 1.18

Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci (2002) 1.18

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res (2013) 1.17

In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A (1980) 1.15

Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell Mol Life Sci (2013) 1.14

Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology (2013) 1.07

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas (2014) 1.05

VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol (2012) 1.03

Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem (2006) 1.01

The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med (2008) 0.99

1α,25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem (2012) 0.96

Sarcopenia and fragility fractures. Eur J Phys Rehabil Med (2013) 0.96

Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int (1978) 0.95

Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology (2013) 0.94

Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells. Endocr Relat Cancer (2005) 0.93

24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology (1997) 0.92

Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells. J Steroid Biochem Mol Biol (2013) 0.92

Defining Akt actions in muscle differentiation. Am J Physiol Cell Physiol (2012) 0.91

CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol (2010) 0.91

The effect of cell density on the maturation and contractile ability of muscle derived cells in a 3D tissue-engineered skeletal muscle model and determination of the cellular and mechanical stimuli required for the synthesis of a postural phenotype. J Cell Physiol (2010) 0.90

Effects of 1 alpha-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on bone remodeling. Calcif Tissue Int (1980) 0.88

Rapid changes in skeletal muscle calcium uptake induced in vitro by 1,25-dihydroxyvitamin D3 are suppressed by calcium channel blockers. Endocrinology (1987) 0.86

Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta (1989) 0.86

24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells. Mol Endocrinol (2014) 0.85

MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line. J Cell Biochem (2006) 0.85

1α,25-dihydroxyvitamin D₃ enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int (2012) 0.83

Activation of MAPKs by 1alpha,25(OH)2-Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J Steroid Biochem Mol Biol (2007) 0.83

Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr (2013) 0.83

Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines. Muscle Nerve (2014) 0.82

Regulation of the CYP27B1 5'-flanking region by transforming growth factor-beta in ROS 17/2.8 osteoblast-like cells. J Steroid Biochem Mol Biol (2007) 0.81

Participation of protein kinase C alpha in 1,25-dihydroxy-vitamin D3 regulation of chick myoblast proliferation and differentiation. Mol Cell Endocrinol (1999) 0.81

Modulation of calcium uptake in cultured cardiac muscle cells by 1,25-dihydroxyvitamin D3. J Mol Cell Cardiol (1994) 0.81

Supplemental vitamin D3 and zilpaterol hydrochloride. II. Effect on calcium concentration, muscle fiber type, and calpain gene expression of feedlot steers. J Anim Sci (2013) 0.81

Induction of specific proteins in cultured skeletal muscle cells by 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta (1989) 0.80

Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3. PLoS One (2014) 0.80

Effects of alfacalcidol on circulating cytokines and growth factors in rat skeletal muscle. J Physiol Sci (2011) 0.79

24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells. Exp Cell Res (1998) 0.78

Bone-forming ability of 24R,25-dihydroxyvitamin D3 in the hypophosphatemic mouse. J Bone Miner Res (1994) 0.77

Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat. Calcif Tissue Int (1997) 0.77

Effects of alfacalcidol on the contractile properties of the gastrocnemius medialis muscle in adult and old rats. J Physiol Pharmacol (2011) 0.77

Synergistic effect of vitamin D derivatives and retinoids on C2C12 skeletal muscle cells. IUBMB Life (2002) 0.77

Inhibition of membrane L-type calcium channel activity and intracellular calcium concentration by 24R, 25-dihydroxyvitamin D3 in vascular smooth muscle. Steroids (1996) 0.76

The cellular and molecular regulation of 1,25(OH)2D3 production. J Steroid Biochem Mol Biol (1992) 0.76

Nutritional determinants of bone health. J Nutr Elder (2008) 0.76

The phospholipid and fatty acid composition of skeletal muscle cells during culture in the presence of vitamin D-3 metabolites. Biochim Biophys Acta (1987) 0.76